Nanoform Finland (Sweden) Today
| NANOFS Stock | SEK 17.10 1.12 6.15% |
Performance0 of 100
| Odds Of DistressOver 67
|
Nanoform Finland is trading at 17.10 as of the 28th of November 2024, a 6.15 percent decrease since the beginning of the trading day. The stock's open price was 18.22. Nanoform Finland has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Nanoform Finland Plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Nanoform Finland Oy provides nanotechnology and drug particle engineering services for the pharmaceutical and biotechnology industries in Finland and internationally. The company was founded in 2015 and is headquartered in Helsinki, Finland. Nanoform Finland operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 78.39 M outstanding shares. More on Nanoform Finland Plc
Moving together with Nanoform Stock
Moving against Nanoform Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nanoform Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nanoform Finland's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanoform Finland or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Nanoform Finland Plc (NANOFS) is traded on Stockholm Exchange in Sweden and employs 143 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanoform Finland's market, we take the total number of its shares issued and multiply it by Nanoform Finland's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nanoform Finland Plc operates under Healthcare sector and is part of Biotechnology industry. The entity has 78.39 M outstanding shares.
Nanoform Finland Plc has accumulated about 94.82 M in cash with (14.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Check Nanoform Finland Probability Of Bankruptcy
Ownership AllocationNanoform Finland Plc maintains a total of 78.39 Million outstanding shares. Over half of Nanoform Finland's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Nanoform Finland Plc. Please watch out for any change in the institutional holdings of Nanoform Finland Plc as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nanoform Ownership Details
Nanoform Finland Plc Risk Profiles
Although Nanoform Finland's alpha and beta are two of the key measurements used to evaluate Nanoform Finland's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.46 | |||
| Standard Deviation | 3.82 | |||
| Variance | 14.57 | |||
| Risk Adjusted Performance | (0.03) |
Nanoform Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nanoform Finland without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Nanoform Finland Corporate Management
Elected by the shareholders, the Nanoform Finland's board of directors comprises two types of representatives: Nanoform Finland inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanoform. The board's role is to monitor Nanoform Finland's management team and ensure that shareholders' interests are well served. Nanoform Finland's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanoform Finland's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rowe | Head Manufacturing | Profile | |
| Pr Haeggstrom | CoFounder CEO | Profile | |
| Christian Jones | Chief Officer | Profile | |
| Albert Haeggstrom | CFO Director | Profile | |
| Henri Haartman | Director Relations | Profile | |
| Peter Hanninen | G Counsel | Profile | |
| Johanna MSocSc | Director HR | Profile |
Other Information on Investing in Nanoform Stock
Nanoform Finland financial ratios help investors to determine whether Nanoform Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanoform with respect to the benefits of owning Nanoform Finland security.